» Articles » PMID: 36653420

A Rodent Model for Dirofilaria Immitis, Canine Heartworm: Parasite Growth, Development, and Drug Sensitivity in NSG Mice

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jan 18
PMID 36653420
Authors
Affiliations
Soon will be listed here.
Abstract

Heartworm disease, caused by Dirofilaria immitis, remains a significant threat to canines and felines. The development of parasites resistant to macrocyclic lactones (ML) has created a significant challenge to the control of the infection. The goal of this study was to determine if mice lacking a functional immune response would be susceptible to D. immitis. Immunodeficient NSG mice were susceptible to the infection, sustaining parasites for at least 15 weeks, with infective third-stage larvae molting and developing into the late fourth-stage larvae. Proteomic analysis of host responses to the infection revealed a complex pattern of changes after infection, with at least some of the responses directed at reducing immune control mechanisms that remain in NSG mice. NSG mice were infected with isolates of D. immitis that were either susceptible or resistant to MLs, as a population. The susceptible isolate was killed by ivermectin whereas the resistant isolate had improved survivability, while both isolates were affected by moxidectin. It was concluded that D. immitis survives in NSG mice for at least 15 weeks. NSG mice provide an ideal model for monitoring host responses to the infection and for testing parasites in vivo for susceptibility to direct chemotherapeutic activity of new agents.

Citing Articles

Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research.

Dagley J, DiCosty U, Fricks C, Mansour A, McCall S, McCall J F1000Res. 2024; 13:484.

PMID: 39036651 PMC: 11259772. DOI: 10.12688/f1000research.149854.1.


Development of a novel rodent model for dog heartworm microfilaremia using the severe-combined immunodeficiency mouse.

Mizuseki M, Ikeda N, Shirozu T, Yamagishi M, Oshiro S, Fukumoto S Sci Rep. 2024; 14(1):13741.

PMID: 38877072 PMC: 11178764. DOI: 10.1038/s41598-024-63165-x.


Comparative development of human filariae and in immunocompromised mouse strains.

Chunda V, Fombad F, Kien C, Ebai R, Esofi F, Ntuh A Front Trop Dis. 2024; 5:1293632.

PMID: 38655273 PMC: 7615855. DOI: 10.3389/fitd.2024.1293632.


New paradigms in research on Dirofilaria immitis.

Geary T Parasit Vectors. 2023; 16(1):247.

PMID: 37480077 PMC: 10362759. DOI: 10.1186/s13071-023-05762-9.


Dirofilariasis mouse models for heartworm preclinical research.

Marriott A, Dagley J, Hegde S, Steven A, Fricks C, DiCosty U Front Microbiol. 2023; 14:1208301.

PMID: 37426014 PMC: 10324412. DOI: 10.3389/fmicb.2023.1208301.

References
1.
Evans K, Wit J, Stevens L, Hahnel S, Rodriguez B, Park G . Two novel loci underlie natural differences in Caenorhabditis elegans abamectin responses. PLoS Pathog. 2021; 17(3):e1009297. PMC: 7993787. DOI: 10.1371/journal.ppat.1009297. View

2.
Serreze D, Gaskins H, Leiter E . Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol. 1993; 150(6):2534-43. View

3.
Wolstenholme A . Glutamate-gated chloride channels. J Biol Chem. 2012; 287(48):40232-8. PMC: 3504739. DOI: 10.1074/jbc.R112.406280. View

4.
Brehm M, Wiles M, Greiner D, Shultz L . Generation of improved humanized mouse models for human infectious diseases. J Immunol Methods. 2014; 410:3-17. PMC: 4155027. DOI: 10.1016/j.jim.2014.02.011. View

5.
Abraham D, Grieve R, Seibert B . Active and passive immunization of mice against larval Dirofilaria immitis. J Parasitol. 1988; 74(2):275-82. View